Can Bladder Cancer Cystoscopy Follow-Up Stop After 5 Years? New Study

1 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

Published
Surveillance Cystoscopy Can Be Safely Reduced or Stopped After 60 Months in Intermediate Risk NMIBC | UroNurse News

Welcome to UroNurse News, your trusted source for the latest updates in urology, bladder cancer research, and patient care innovations. Hosted and presented by Vic Senese, RN, BSN, FAUNA, this episode explores new research examining whether routine surveillance cystoscopy can safely be reduced or even stopped after 60 months for selected patients with intermediate-risk non-muscle invasive bladder cancer (NMIBC).

For many bladder cancer survivors, lifelong cystoscopy appointments can create physical, emotional, and financial burdens. This emerging research looks at whether patients who remain cancer-free for five years may safely reduce the frequency of surveillance procedures while maintaining appropriate cancer monitoring.

In this episode of UroNurse News, we discuss:

✅ What intermediate-risk NMIBC means
✅ Why cystoscopy remains the gold standard for bladder cancer surveillance
✅ How recurrence risk changes over time after treatment
✅ The importance of the 60-month (5-year) milestone
✅ Which patients may be candidates for reduced surveillance schedules
✅ The balance between early cancer detection and reducing unnecessary procedures
✅ What this research could mean for the future of bladder cancer follow-up care

Non-muscle invasive bladder cancer (NMIBC) is one of the most common forms of bladder cancer, and surveillance cystoscopy plays a critical role in detecting recurrence. However, researchers continue to evaluate personalized follow-up strategies that provide safe cancer monitoring while improving quality of life for patients.

This discussion is designed to help patients, caregivers, nurses, and healthcare professionals better understand evolving approaches to bladder cancer surveillance.

Categoria
Urology
Commenta per primo questo video.

Prossimo